Accelerating Access to Lifesaving Technologies for Cancer Patients
"If you're a cancer patient today, you don't want tomorrow's solutions. You want today's solutions." That's why Bob Crutchfield is leading the American Cancer Society's efforts to drive the best ideas to market faster, so cancer patients can benefit from less invasive – and more successful – treatments. Mr. Crutchfield is the Managing Director of BrightEdge, the Philanthropic Impact Fund of the American Cancer Society, which invests in for-profit companies in order to advance the speed of commercial adoption of novel and innovative therapies, diagnostics, devices, and technologies.